𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Kinetic and equilibrium analyses of [123I]epidepride binding to striatal and extrastriatal dopamine D2 receptors

✍ Scribed by Masahiro Fujita; John P. Seibyl; N. Paul L.G. Verhoeff; Masanori Ichise; Ronald M. Baldwin; Sami S. Zoghbi; Cyrill Burger; Julie K. Staley; Nallakkandi Rajeevan; Dennis S. Charney; Robert B. Innis


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
327 KB
Volume
34
Category
Article
ISSN
0887-4476

No coin nor oath required. For personal study only.

✦ Synopsis


Quantitative SPECT measures of dopamine D 2 like receptors with [ 123 I]epidepride is complicated by its high affinity and lipophilic metabolites. The purpose of this study was to use both parent (P) and lipophilic metabolites (M) as input functions in a kinetic paradigm and in comparison to the results of equilibrium studies. Kinetic studies on eleven healthy human subjects, ages 32 Ϯ 10 were performed following i.v. injection of ϳ370 MBq of [ 123 I]epidepride. Images were acquired for 13.5 Ϯ 1.0 hours. Equilibrium studies were done on seven of eleven subjects with a bolus injection of ϳ140 MBq, bolus/infusion ratio of 10 hours, and infusion for 30-32 hours. High (striatum) and low (temporal cortex) density regions were studied. Two (P and M) and one (P) input function models were applied in the kinetic studies. In receptor-rich regions, the distribution volumes in nondisplaceable compartments were fixed to those in cerebellum. In addition, in the two input function model, K 1 P /K 1 M was fixed to the values in the cerebellum. The one input function model provided VЈ 3 values (ϭf 1 BЈ max /K D ) which were consistent with those obtained in equilibrium studies in both receptor-rich regions, while the two input function model provided consistent values only in striatum. Poor identifiability of the rate constants of metabolites seemed to be the source of errors in the two input function model. These results suggest that correct VЈ 3 values can be obtained with the one input function model both in high-and low-density regions.


📜 SIMILAR VOLUMES


Preparation of [123I]- and [125I]epidepr
✍ J. A. Clanton; T. de Paulis; D. E. Schmidt; M. S. Ansari; R. G. Manning; R. M. B 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 412 KB

## Abstract (__S__)‐(−)‐__N__‐[(1‐ethyl‐2‐pyrrolidinyl)methyl]‐5‐[^123^I]iodo‐2,3‐dimethoxybenzamide (TDP 517) (proposed generic name, [^123^I]epidepride) is the iodine‐123 substituted analogue of isoremoxipride (FLB 457), both of which are very potent dopamine D‐2 antagonists (epidepride K~D~ 0.02

Steele-Richardson-Olszewski-Syndrome: Re
✍ Guy Arnold; Klaus Tatsch; Eduardo Kraft; Wolfgang H. Oertel; Johannes Schwarz 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

Patients with the clinical diagnosis of progressive supranuclear palsy (PSP) show heterogeneous neuropathological findings. In neuropathologically proven cases with numerous neurofibrillary tangles of neuropil threads, the brainstem and striatum are always affected. We compared (123)I-iodobenzamide